Glucommander for Outpatient Insulin Titration

Bruce Bode, MD

American Diabetes Association Scientific Sessions, June 2016

Dr. Bruce Bode, diabetologist and head of research at Atlanta Diabetes Associates, and Clinical Associate Professor of Medicine at Emory University, discusses the results of a study involving use of Glucommander for insulin dosing decision support to help titrate outpatients to A1C goal.

Integrated Insulin Algorithms for CV Surgery Patients

Valerie Garrett, MD

American Diabetes Association Scientific Sessions, June 2016

Dr. Valerie Garrett, hospitalist and Medical Director Diabetes Center at Mission Hospital, discusses program effectiveness around use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing the Monarch Medical Technologies EndoTool solution with the Glytec Glucommander solution.

Comparing Glucommander to EndoTool

Valerie Garrett, MD

American Diabetes Association Scientific Sessions, June 2016

Dr. Valerie Garrett, hospitalist and Medical Director Diabetes Center at Mission Hospital, discusses improvements in the quality and safety of patient care resulting from changes to insulin management protocols, including a transition from the Monarch Medical Technologies EndoTool solution to the Glytec Glucommander solution.

Use of Glucommander for Resolution of DKA

Guillermo Umpierrez, MD

American Diabetes Association Scientific Sessions, June 2016

Dr. Guillermo Umpierrez, Professor of Medicine and Director of the Clinical Research, Diabetes and Metabolism Center at Emory University School of Medicine and Director of Diabetes and Endocrinology at Grady Hospital, discusses use of Glucommander for management of diabetic ketoacidosis.

Measuring Costs of Hypoglycemia in Hospital Patients

Jagdeesh Ullal, MD, MS, CCD, ECNU, FACE, FACP

American Diabetes Association Scientific Sessions, June 2016

Dr. Jagdeesh Ullal, endocrinologist and Associate Professor at Eastern Virginia Medical School, discusses the impact of hypoglycemia on cost of inpatient care, including length of stay.

Glucommander IV for Treatment of DKA

Joseph Aloi, MD

American Association of Clinical Endocrinologists Annual Meeting, May 2016

Dr. Joseph Aloi, Section Chief of Endocrinology and Metabolism of Wake Forest Baptist Medical Center and former Clinical Director of Eastern Virginia Medical School's Strelitz Diabetes Center, discusses the results of research comparing use of Glucommander for IV insulin dosing to that of usual care (most typically, an order set in the EMR) for treatment of diabetic ketoacidosis.

Preventing Insulin Errors

Joseph Aloi, MD

American Association of Clinical Endocrinologists Annual Meeting, May 2016

Dr. Joseph Aloi, Section Chief of Endocrinology and Metabolism of Wake Forest Baptist Medical Center and former Clinical Director of Eastern Virginia Medical School's Strelitz Diabetes Center, discusses how using Glucommander helps prevent medication errors involving insulin.

ArrowArrow
MD Magazine Interviews Dr. Bruce Bode
Glucommander for Outpatient Insulin Titration
MD Magazine Interviews Dr. Valerie Garrett
Integrated Insulin Algorithms for CV Surgery Patients
MedPage Today Interviews Dr. Valerie Garrett
Comparing Glucommander to EndoTool
MedPage Today Interviews Dr. Guillermo Umpierrez
Use of Glucommander for Resolution of DKA
MD Magazine Interviews Dr. Jagdeesh Ullal
Measuring Costs of Hypoglycemia in Hospital Patients
Diabetes in Control Interviews Dr. Joseph Aloi
Glucommander IV for Treatment of DKA
Diabetes in Control Interviews Dr. Joseph Aloi
Preventing Insulin Errors